4.1 Article

The 12q14 microdeletion syndrome: Additional patients and further evidence that HMGA2 is an important genetic determinant for human height

期刊

EUROPEAN JOURNAL OF MEDICAL GENETICS
卷 52, 期 2-3, 页码 101-107

出版社

ELSEVIER SCIENCE BV
DOI: 10.1016/j.ejmg.2009.03.001

关键词

12q14 Microdeletion syndrome; Osteopoikilosis; Buschke-Ollendorff; Short stature; Mental retardation; LEMD3; HMGA2

资金

  1. FWO [0200.03, 36027907]
  2. Ghent University [12051203]
  3. Research Foundation - Flanders (FWO)
  4. Netherlands Organisation for Health Research and Development
  5. AnEUploidy [LSHG-CT-2006-037627]
  6. European Commission under FP6

向作者/读者索取更多资源

Characteristic features of the 12q14 microdeletion syndrome include low birth weight, failure to thrive, short stature, learning disabilities and Buschke-Ollendorff lesions in bone and skin. This report on two additional patients with this microdeletion syndrome emphasizes the rather constant and uniform phenotype encountered in this disorder and refines the critical region to a 2.61 Mb interval on 12q14.3, encompassing 10 RefSeq genes. We have previously shown that LEMD3 haploinsufficiency is responsible for the Buschke-Ollendorff lesions and now provide strong evidence that a heterozygous deletion of HMGA2 is causing the growth failure observed in this disorder. The identification of an intragenic HMGA2 deletion in a boy with proportionate short stature and the cosegregation of this deletion with reduced adult height in the extended family of the boy further underscore the role of HMGA2 in regulating human linear growth. (C) 2009 Elsevier Masson SAS. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.1
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据